Table 1.

Baseline characteristics, n = 28 patients.

	SARS-CoV-2 Positive (n = 24)	SARS-CoV-2 Negative (n = 4)
Age, years ± standard deviation	71 ± 15	70 ± 7
Male	16/24 (67%)	3/4 (75%)
Ethnicity/Race
•Hispanic	8 (33%)	0 (0%)
•Non-Hispanic Black or African American	7 (29%)	0 (0%)
•Non-Hispanic White	2 (8%)	2 (50%)
•Non-Hispanic Asian	2 (8%)	0 (0%)
•Non-Hispanic Other	0 (0%)	1 (25%)
•Declined	5 (21%)	1 (25%)
Body mass index, kg/m2	29.6 ± 8.3	22.7 ± 3.0
Diabetes mellitus	13/24 (54%)	1/4 (25%)
Hypertension	19/24 (79%)	3/4 (75%)
Chronic kidney disease, stage III or worse	4/20 (20%)	0/1 (0%)
•End stage renal disease	2	0
Prior stroke	3/24 (13%)	0/4 (0%)
Dementia	3/24 (13%)	0/4 (0%)
Chronic obstructive pulmonary disease	3/24 (13%)	0/4 (0%)
Prior coronary artery disease	7/24 (29%)	1/4 (25%)
Prior congestive heart failure	10/24 (42%)	2/4 (50%)
•Durable Left Ventricular Assist Device	1	0
Prior atrial fibrillation	3/24 (13%)	1/4 (25%)
•Paroxysmal	3	1
•Persistent	0	0
•Chronic	0	0
•Prior AF ablation, DCCV, AAD use	0	0
Prior cardiac implantable electronic device	7/24 (29%)	2/4 (50%)
•Pacemaker	2	0
•ICD	5	2